Physician profile
Jonathan Su
NPI 1801391123
$7,034.91
in general payments reported to CMS, 2019-2025
6 companies · $5,918 in 2025
The $5,918 reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $21.42 · 2024: $1,095 · 2025: $5,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,263 · Food and Beverage: $3,186 · Education: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,262.96 |
| Food and Beverage | $3,186.02 |
| Education | $585.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,463.71 | 2024-2025 | Farapulse, Accolade Sr, Emblem Mri S-Icd |
| Medtronic, INC. | $1,649.34 | 2024-2025 | Evera Mri Xt Dr Surescan, Micra, Harmony |
| Biosense Webster, INC. | $1,595.04 | 2025 | Carto 3, Octaray Mapping Catheter |
| Abbott Laboratories | $1,296.28 | 2024-2025 | Accent, Ensite, Aveir |
| Sanofi Pasteur INC. | $21.42 | 2023 | |
| Altathera Pharmaceuticals LLC | $9.12 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.